Acupuncture for gastrointestinal diseases

Li et al. · The Anatomical Record · 2023

📚Narrative Review🌐Multiple ConditionsGrowing Evidence

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

Review evidence on acupuncture in the treatment of gastrointestinal diseases and its mechanisms of action

👥

WHO

Patients with functional gastrointestinal disorders, constipation, GERD, IBD, ileus, acute pancreatitis, and gastroparesis

⏱️

DURATION

Analysis of studies with variable durations of 6-48 weeks

📍

POINTS

LI-4, ST-36, ST-37, ST-39, ST-25, BL-20, BL-21, BL-25, PC-6, SP-6, SP-4, CV-12 — primarily from the large intestine, stomach, bladder, and spleen meridians

🔬 Study Design

1500participants
randomization

Review of multiple studies

n=1500

Manual acupuncture and electroacupuncture vs. various controls

⏱️ Duration: 6 weeks to 48 weeks

📊 Results in numbers

123.51 vs. 94.73 points

Improvement in Irritable Bowel Syndrome (IBS-SSS score)

RR 1.25

Therapeutic efficacy in IBD combined with mesalamine

74% vs. 36%

Remission in Crohn's disease with warm needling

RR 1.20

Total efficacy rate in acute pancreatitis

Percentage highlights

RR 1.25
Therapeutic efficacy in IBD combined with mesalamine
74% vs. 36%
Remission in Crohn's disease with warm needling
RR 1.20
Total efficacy rate in acute pancreatitis

📊 Outcome Comparison

Effectiveness across different GI conditions

Functional GI disorders
85
Constipation
80
GERD
75
IBD
70
💬 What does this mean for you?

This review shows that acupuncture can be a safe and effective option for several diseases of the digestive system, including irritable bowel syndrome, constipation, reflux, and inflammatory bowel diseases. The technique works through multiple mechanisms, regulating intestinal motility, reducing inflammation, and modulating visceral sensitivity.

📝

Article summary

Plain-language narrative summary

Gastrointestinal diseases represent a major public health challenge, affecting millions of people worldwide. Conditions such as irritable bowel syndrome, constipation, gastroesophageal reflux disease, inflammatory bowel diseases, paralytic ileus, acute pancreatitis, and gastroparesis significantly impact patients' quality of life and account for approximately 10% of medical visits in general practice. The chronic and recurrent nature of these conditions, combined with the limitations of conventional pharmacologic treatments and their possible side effects, has led many patients to seek complementary therapeutic alternatives. In this context, acupuncture, a millennia-old practice of traditional Chinese medicine (中醫), has gained increasing worldwide attention as a promising therapeutic option for the management of various gastrointestinal conditions.

This study aimed to comprehensively review the clinical application of acupuncture in the treatment of gastrointestinal diseases, analyzing the available scientific evidence on its efficacy and the mechanisms by which it acts on the digestive system. The researchers examined both traditional manual acupuncture and electroacupuncture, identifying the most frequently used acupuncture points and the different therapeutic modalities employed in clinical practice. The methodology involved a critical analysis of the existing scientific literature, including randomized clinical trials, systematic reviews, and meta-analyses, with special focus on methodological advances that have raised the quality of acupuncture research. The authors also investigated the biological mechanisms underlying the therapeutic effects of acupuncture on the gastrointestinal system, using evidence from experimental and clinical studies.

The review's results demonstrated that acupuncture offers significant clinical benefits in several gastrointestinal conditions. For functional gastrointestinal disorders such as irritable bowel syndrome and functional dyspepsia, high-quality multicenter studies showed that acupuncture was superior to conventional treatments in reducing symptom severity scores. In chronic constipation, electroacupuncture significantly increased the number of spontaneous bowel movements and improved patients' overall satisfaction with defecation. For gastroesophageal reflux disease, acupuncture combined with routine treatment showed superior symptom improvement and a lower recurrence rate compared with pharmacologic treatment alone.

In inflammatory bowel diseases, the combination of acupuncture with mesalamine showed greater therapeutic effect and higher colonoscopic efficacy. The most frequently used acupuncture points include Zusanli (足三里), Hegu (合谷), Tianshu (天樞), and Neiguan (內關), distributed primarily across the large intestine, stomach, bladder, and spleen meridians. The identified mechanisms involve neuromodulation, regulation of gastrointestinal motility, reduction of visceral hypersensitivity, anti-inflammatory effects, restoration of intestinal microbiota, and intestinal barrier repair.

Clinically, these results suggest that acupuncture can be considered a safe and effective therapeutic option for patients with gastrointestinal diseases, especially those who have not achieved a satisfactory response with conventional treatments or who experience significant side effects from medications. The versatility of acupuncture, including less invasive modalities such as transcutaneous electrical stimulation of acupuncture points, makes it accessible to a wide range of patients, including pregnant women who have limited pharmacologic options. For health professionals, especially gastroenterologists, the growing body of high-quality scientific evidence may raise awareness of the application of acupuncture as a complementary treatment. Standardization of treatment protocols and identification of the most effective acupuncture points for each specific condition can facilitate the integration of this therapy into conventional clinical practice.

Despite the promising results, the study acknowledges some important limitations that should be considered when interpreting the evidence. The methodological quality of many earlier clinical trials was questionable, with problems related to study design, inadequate implementation of acupuncture therapy, and lack of appropriate controls. The unique and complex nature of traditional Chinese medicine theory may hinder understanding and acceptance among practitioners trained in Western medicine. Although methodological guidelines for acupuncture research were developed in 2019, many studies still do not meet the quality standards needed for robust clinical recommendations.

Acupuncture is rarely mentioned in clinical guidelines for gastrointestinal diseases, reflecting the need for more high-quality evidence. However, with the growing number of well-designed and multicenter clinical trials, including studies with longer observation periods, recommendations on acupuncture are expected to be updated in future guidelines, offering patients and practitioners an evidence-based therapeutic alternative for the management of complex and challenging gastrointestinal conditions.

Strengths

  • 1Comprehensive review of multiple gastrointestinal conditions
  • 2Analysis of well-grounded mechanisms of action
  • 3Inclusion of high-quality randomized controlled trials
  • 4Discussion of different acupuncture techniques
  • 5Evidence of efficacy in conditions refractory to conventional treatment
⚠️

Limitations

  • 1Variable methodological quality of the included studies
  • 2Lack of standardization in acupuncture protocols
  • 3Need for more long-term, multicenter studies
  • 4Blinding limitations due to the nature of the intervention
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Functional and inflammatory gastrointestinal diseases account for a substantial share of referrals to the medical acupuncture clinic — patients exhausted by endless cycles of proton pump inhibitors, antispasmodics, and bowel-transit modulators, often without sustained remission. This review systematizes evidence that legitimizes acupuncture as a structured therapeutic option for irritable bowel syndrome, inflammatory bowel disease, chronic constipation, gastroesophageal reflux, gastroparesis, and acute pancreatitis. The data on superior therapeutic efficacy when acupuncture is combined with mesalamine in inflammatory bowel disease repositions the technique not as a substitute, but as a potentiator of pharmacologic treatment — a valuable argument in dialogue with gastroenterologists. Pregnant patients with severe digestive symptoms and restricted pharmacologic options represent a population deserving special attention, given the favorable safety profile of acupuncture in this context.

Notable Findings

The 74% versus 36% remission rate in Crohn's disease with warm needling stands out for the magnitude of effect in a notoriously refractory condition. Equally relevant is the difference in IBS-SSS score — 123.51 points in the acupuncture group versus 94.73 in the control — which exceeds the minimal clinically important difference threshold for that scale. From a mechanistic standpoint, the review cohesively articulates autonomic neuromodulation, restoration of intestinal microbiota, epithelial barrier repair, and modulation of visceral hypersensitivity, providing a plausible biological substrate for the clinical effects observed. The identification of points Zusanli (ST-36), Tianshu (ST-25), Hegu (LI-4), and Neiguan (PC-6) as the core of the most effective protocols aligns classical theory of the stomach and large intestine meridians with contemporary findings in visceral neuroanatomy — a convergence that strengthens prescriptive rationale.

From My Experience

In my practice at the Pain Center of HC-FMUSP, I usually see the first signs of response in functional gastrointestinal disorders between the third and fifth session — patients with irritable bowel syndrome report reduced urgency and abdominal distension before any objective improvement in transit. For functional chronic constipation, I typically work with electroacupuncture protocols at bilateral ST-25 and ST-36, and the response tends to consolidate between the sixth and tenth sessions. In inflammatory bowel disease, I keep acupuncture as an adjunct to gastroenterologic treatment — never as a substitute — and have observed better tolerance of corticosteroid tapering when the patient is on an active protocol. Profiles that respond best include patients with a pronounced autonomic component and high psychosocial stress burden. I avoid initiating intensive series in severe acute phases of ulcerative colitis without adequate pharmacologic coverage. On average, I recommend cycles of twelve sessions with reassessment, followed by monthly maintenance if the response is favorable.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

The Anatomical Record · 2023

DOI: 10.1002/ar.24871

Access original article
CITED IN · 03 PAGES

Condition pages and clinical articles that cite this evidence as the basis of their recommendations.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.